Patients may now switch between Stelara and Selarsdi, in all matching presentations, without prescriber intervention. The Food and Drug Administration (FDA) has approved Selarsdi ™ (ustekinumab-aken) ...

Drug manufacturers will have 30 days to lower the cost of prescription drugs in the United States or face new limits over what the government will pay. HealthDay News — President Donald Trump signed ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Fresh & Ready Foods has voluntarily recalled products with “use by” dates from April 22 to May 19, 2025, CNN said. The items were sold under the brand names Fresh & Ready Foods, City Point Market ...

Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery use among adolescents increased.

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.